Transcript of Clean Science and Technology's Q3 FY25-26 earnings call highlights MEHQ price declines due to cheaper Chinese hydroquinone, tariff-induced volume pressures on BHA, and no current domestic competition for MEHQ/BHA, with management prioritizing volumes amid pricing challenges.